NCT06481293

Brief Summary

This study examines the efficiency of diode laser therapy to manage dry sockets after tooth extraction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2025

Completed
Last Updated

September 25, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

June 25, 2024

Last Update Submit

September 21, 2025

Conditions

Alveolar Osteitis

Keywords

Diode laserDry socket

Outcome Measures

Primary Outcomes (1)

  • Socket volume

    measured through the volumetric measurement method using a syringe filled with saline

    2 weeks

Secondary Outcomes (1)

  • Pain level

    2 weeks

Study Arms (2)

Group 1

EXPERIMENTAL

Group 1 received diode laser therapy

Device: Diode laser therapy

group 2

EXPERIMENTAL

Group 2 received topical application of aveogl dressing

Combination Product: Alveogyl dressing

Interventions

Diode laser therapyDEVICE

Dual wavelength laser diode therapy device

Group 1
Alveogyl dressingCOMBINATION_PRODUCT

Alveogyl is a haemostatic-analgesic alveolar dressing

group 2

Eligibility Criteria

Age25 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Smokers patient

You may not qualify if:

  • Females on contraceptives.
  • Diabetic patients
  • Hepatitis C virus patients
  • Patients on corticosteroids
  • Patients with renal diseases
  • Anemic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Badr University in Cairo

Cairo, 11837, Egypt

Location

MeSH Terms

Conditions

Dry Socket

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

  • reham Elkalla, lecturer

    Badr University in Cairo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study included two groups. One group receives dual wavelength laser diode therapy and the other group receives topical aveogyl dressing.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of physical therapy

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 1, 2024

Study Start

October 30, 2023

Primary Completion

September 20, 2024

Study Completion

September 20, 2025

Last Updated

September 25, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)